Skip to content
LSE:ADM$3,904.00+32.00(+0.83%)Treasury's Refunding Details Are Up Next as Five Large Companies Report Higher Revenue7:00:29 AM ETLLY$1,434.84+25.83(+1.83%)Treasury's Refunding Details Are Up Next as Five Large Companies Report Higher Revenue Market Updates News Commentary - U.S. stock index futures were mixed early Wednesday after a split session on Tuesday. As of 2:22 a.m. ET, December...7:00:00 AM ETPLTR$169.01-6.33(-3.61%)Changshin and Palantir Partner to Connect Footwear Development and Factory Operations with Data and AI6:59:00 AM ETNVDA$206.66+0.10(+0.05%)Why Nvidia Stock Is Rising as Crackdown on Data Centers Looms6:49:00 AM ETRY$205.00+1.33(+0.65%)Democrat sweep adds new twist to markets' Iran, AI, and debt worries6:46:45 AM ETAPH$84.70+0.52(+0.62%)AI Data Center Demand, Record Sales Send Amphenol Higher6:42:56 AM ETMU$851.00-3.93(-0.46%)SpaceX or Micron: If I Could Only Own One for the Next 5 Years, It Would Be This6:38:00 AM ETPFE$30.37+0.39(+1.30%)Amazon, Pfizer, Eaton And A Financial Stock On CNBC's ‘Final Trades'6:37:07 AM ETADI$428.30+8.50(+2.02%)Semiconductor Sell-Off: The Best Chip Stocks to Buy Right Now Before They Skyrocket Once Again6:36:02 AM ETFDX$318.01-0.24(-0.08%)Jim Cramer Recommends FedEx: ‘Very Nice Move Off The Bottom'6:35:07 AM ETSKHY$150.30-0.57(-0.38%)Why SK Hynix Plunged in October6:30:02 AM ETPLTR$169.01-6.33(-3.61%)Michael Burry shorted Palantir a year ago; Here's how the bet is doing6:27:31 AM ETAAPL$334.74+3.10(+0.93%)Apple Can be an Expensive AI Safe Haven6:26:00 AM ETRTX$198.38-5.45(-2.67%)RTX and Other Defense Stocks Have a Midterm Headache6:24:00 AM ETNVO$42.17+1.97(+4.90%)2 Reasons for Hope From Novo Nordisk Earnings6:20:00 AM ETCRWD$247.90+3.26(+1.33%)Jim Cramer Praises New “AI Kill Switch,” Says “You Should Just Go Buy CrowdStrike”6:19:49 AM ETAMGN$472.00+10.90(+2.36%)BUZZ-Street View: Pipeline catalysts hold key to Amgen's growth6:19:12 AM ETMA$653.03+5.77(+0.89%)Mastercard vs. S&P Global: Which Financial Stock Is a Better Buy for 2027?6:15:02 AM ETAMZN$258.01+7.23(+2.88%)Andy Jassy Just Delivered Magnificent News for Amazon Investors6:12:00 AM ETGOOG$280.50+2.21(+0.79%)Google to Invest $15 Billion in Malaysia Over Two Years6:06:00 AM ETTSLA$376.14-22.20(-5.57%)Tesla and SpaceX shares drop after Elon Musk's election bet backfires6:05:20 AM ETCAT$614.00-9.84(-1.58%)Caterpillar Inc. $CAT Shares Newly Acquired by Associated Banc Corp6:04:12 AM ETSPCX$132.75-8.58(-6.07%)Prediction: This Will Be SpaceX's Stock Price by the End of 20276:00:00 AM ETQCOM$164.90+0.47(+0.29%)Qualcomm's Smartphone Business Is Hurting. Data Centers Could Fuel Its Next Act.6:00:00 AM ET

TEM · NASDAQ

Tempus AI, Inc.

$79.33 +1.56 (+2.01%)

Company overview

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a licensed library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials, which provides clinical trial matching services to pharmaceutical companies.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Market cap
$14.1B
Employees
2,400
Headquarters
Chicago, IL
Website
tempus.com
CEO
Eric Lefkofsky
Listed
June 14, 2024
P/E
-46.39
Dividend yield
0.00%

Company financials

Revenue
$1.4B
Gross profit
$949M
Operating income
-$247M
EBITDA
-$200M
Net income
-$303M
EPS
-$1.71
Total assets
$2.1B
Total debt
$815M
Gross margin
69.55%
Net margin
-22.20%
Earnings yield
-2.16%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

38.8451.8864.9377.9891.02
TEM 1D NASDAQ O80.75H84.47L77.60C77.77-0.71 (-0.90%)Vol5.62M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
TEMTempus AI, Inc. Stock news Tempus AI: An Inflection Point Has Arrived (Earnings Analysis) Seeking Alpha
TEMTempus AI, Inc. Stock news Ceribell Q3 loss misses estimates; raises 2026 revenue guidance Reuters
TEMTempus AI, Inc. Stock news Tempus AI Surges on Earnings Beat, But Can the Rally Last? MarketBeat
TEMTempus AI, Inc. Stock news TEM Q3 Earnings Call Highlights Growth and 2027 Pricing Upside Zacks Investment Research
TEMTempus AI, Inc. Stock news Baron SMID Cap ETF Q3 2026 Contributors And Detractors Seeking Alpha
TEMTempus AI, Inc. Stock news Upstart Q3 net income up on record contribution profit Reuters
TEMTempus AI, Inc. Stock news Manufacturing marketplace Xometry beats Q3 estimates; raises FY revenue outlook Reuters
TEMTempus AI, Inc. Stock news Tempus AI Analysts Boost Their Forecasts Following Strong Q3 Results Benzinga
TEMTempus AI, Inc. Stock news Waystar Q3 revenue, adjusted profit beat estimates on subscription growth Reuters
TEMTempus AI, Inc. Stock news Cloud storage provider Backblaze's Q3 revenue beats; raises FY outlook Reuters
TEMTempus AI, Inc. Stock news Paymentus Q3 revenue beats on higher billers and transaction volumes Reuters
TEMTempus AI, Inc. Stock news Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge 24/7 Wall Street
TEMTempus AI, Inc. Stock news Tempus AI, Inc. (TEM) Q3 2026 Earnings Call Transcript Seeking Alpha
TEMTempus AI, Inc. Stock news Tempus AI Says It Is Uniquely Positioned Benzinga
TEMTempus AI, Inc. Stock news Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say Zacks Investment Research
TEMTempus AI, Inc. Stock news Tempus AI (TEM) Beats Q3 Earnings and Revenue Estimates Zacks Investment Research
TEMTempus AI, Inc. Stock news BUZZ-Tempus AI rises after surprise quarterly profit Reuters
TEMTempus AI, Inc. Stock news What Tempus AI (TEM) Said on Its Q3 Earnings Call MarketBeat
TEMTempus AI, Inc. Stock news Tempus AI Revenue Up 23%; Gains Cut Net Loss: Rapid Earnings Reaction The Motley Fool
TEMTempus AI, Inc. Stock news Tempus AI's Cancer Screen Business Drives Revenue Up 23%, While a Major Purchase Draws Closer Barrons
FAQ

Questions about Tempus AI, Inc.

What does Tempus AI, Inc. do?
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a licensed library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials, which provides clinical trial matching services to pharmaceutical companies.
What is TEM's market cap?
Tempus AI, Inc. (TEM) is a listed stock with a live quote. The latest market cap on this page is $14.1B.
Where is Tempus AI, Inc. headquartered?
Tempus AI, Inc. is headquartered in Chicago, IL.
How do I get TEM news from the API?
Call GET /v1/news?tickers=TEM. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does TEM news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for TEM, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the TEM price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.